News

It has pointed to a lower tendency to cause taste disturbances (dysgeusia) than other compounds ... a P2X3 drug called sivopixant (S-600918) in mid-stage clinical testing for chronic cough ...
Settlement may compensate consumers who bought Robitussin cough medicine products that were falsely marketed as "non-drowsy." ...
The orally-active P2X3 receptor antagonist, also known as BAY1817080, hit the main objective of the study, which was to reduce the average hourly cough frequency based on 24-hour sound recordings ...
Australian scientists developed a novel antiviral that targets the SARS-CoV-2 PLpro enzyme, showing strong preclinical ...
Researchers have shown a new drug compound can prevent long COVID symptoms in mice – a landmark finding that could lead to a future treatment for the debilitating condition.
Imperial College London says that way more of us than you might think (one in 10 Brits) have a “chronic”, or ongoing, cough. The issue may persist for “decades,” they say, and is more ...
The NHS has issued a warning over a slow-developing bacterial infection that usually starts with a cough. While the illness isn't generally as contagious as a common cold, it can be far more ...
Health experts have warned that a cough lasting more than three weeks could be a sign of a deadly disease making a comeback in the UK. The most recent data from the UK Health Security Agency ...
But they ended up discovering something else entirely: the largest organic compounds ever documented on Mars. The compounds date to 3.7 billion years ago—around the same time that life first ...